Ledger.Open graph →
SEC Form D · filed June 4, 2020

CLEVELAND BIOLABS INC

Offering
$1.6M
Sold
$1.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Buffalo, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Anna S. Evdokimova · Buffalo, NYDirectorRandy S. Saluck · Buffalo, NYDirectorChristopher Zosh · Buffalo, NYExecAnthony K. Parell · WOODRIDGE, ILDirectorAlexander S. Andryushechkin · Buffalo, NYDirectorAndrei S. Gudkov, Ph.D., D., Sci · Buffalo, NYExecLangdon S. Miller, Md · Buffalo, NYExecLea S. Verny · Buffalo, NYDirectorDaniil S. Talyanskiy · Buffalo, NYDirectorIvan S. Fedyunin · Buffalo, NYDirectorThomas R. Mika · West Palm Beach, FLDirectorChristopher R. Diamantis · West Palm Beach, FLDirectorAlexander S. Andryushechkin · Buffalo, NYDirectorAndrei S. Gudkov, Ph.D., D., Sci · Buffalo, NYExecLangdon S. Miller, Md · Buffalo, NYExecLea S. Verny · Buffalo, NYDirectorChristopher Zosh · Buffalo, NYExecDaniil S. Talyanskiy · Buffalo, NYDirectorIvan S. Fedyunin · Buffalo, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗